NAHL Group Reports Strong Profit Growth and Significant Debt Reduction in FY2025 Results

NAHL FY2025 results analysis: profit recovery is real, but there is one big caveat

NAHL Group has delivered a much better set of numbers for FY2025. Revenue edged up to £40.0 million, underlying profit before tax jumped to £5.0 million, and net debt more than halved to £3.2 million. For retail investors, that is the headline story – profits are up, cash is coming in, and the balance sheet looks far less stretched.

That said, there is an important nuance. The swing from a statutory loss before tax of £39.1 million in 2024 to a profit before tax of £4.4 million in 2025 looks dramatic, but last year included a £39.9 million non-cash goodwill impairment in the Personal Injury business. So yes, this is a genuine improvement, but the year-on-year comparison is helped by a nasty one-off charge not repeating.

Key FY2025 numbers from NAHL Group plc

Metric	FY2025	FY2024	Change
Group revenue	£40.0 million	£38.8 million	+3.2%
Underlying operating profit	£7.3 million	£3.9 million	+85.0%
Underlying profit before tax	£5.0 million	£1.4 million	+260.0%
Profit/(loss) before tax	£4.4 million	£(39.1) million	n/a
Free cash flow	£3.9 million	£2.6 million	+51.0%
Net debt	£3.2 million	£7.1 million	-54.9%
Basic underlying EPS	8.0p	2.5p	n/a

Why NAHL’s cash generation and debt reduction matter most

For me, the most encouraging part of this update is not the accounting profit. It is the cash. NAHL generated £6.6 million of net cash from operating activities and £3.9 million of free cash flow.

Free cash flow basically means cash left over after running the business, investing modestly, paying lease obligations and LLP member drawings. That matters because cash pays down debt, reduces interest costs and gives management more options.

And that is exactly what happened here. Net debt fell from £7.1 million to £3.2 million by year-end, then fell further to £2.2 million by 31 March 2026. That is serious progress, especially when management points out debt was as high as £21.0 million back in 2019.

There is another useful sign here. Borrowing costs on the revolving credit facility fell by 33% to £0.6 million. Less debt and lower interest expense is a nice combination, and it helps protect future earnings.

Consumer Legal Services drove the recovery in FY2025

The main engine of improvement was Consumer Legal Services. Revenue rose 4.0% to £23.8 million and underlying operating profit surged 118% to £4.4 million.

The biggest fix appears to have been marketing costs in Personal Injury. In 2024, Google algorithm changes and AI overviews pushed up enquiry acquisition costs. In 2025, management says the average cost per enquiry came back to within 2% of the 2023 average. That is a big operational win.

National Accident Helpline generated 13,389 enquiries, down from 19,744, because panel law firms wanted fewer cases and NAHL was cautious on working capital. Lower volume is not ideal, but if buying leads becomes uneconomic, discipline is the right move.

National Accident Law is producing cash, but the case book is shrinking

This is the bit investors should watch closely. NAHL’s in-house law firm, National Accident Law, settled 3,197 claims in 2025 and generated £10.7 million of cash from settlements, up 26% from £8.5 million. That is excellent.

But new enquiries placed into NAL fell to 4,276 from 5,892, and ongoing claims dropped to 7,243 from 8,457. In plain English, the firm is harvesting cash from an existing book of cases faster than it is refilling the pipeline.

Management is open about this. The value of settlements exceeded the value of new claims added, so the book shrank as working capital was managed prudently. That is sensible in the short term, especially when debt reduction is a priority, but it can limit future growth if it goes on too long.

There is still meaningful embedded value here. NAHL estimates the ongoing NAL claims book could generate future revenues of £8.6 million, future gross profits of £6.1 million and future cash of £13.0 million. Useful, yes. Growing, no.

Bush & Co was steady rather than spectacular

The Critical Care division, which includes Bush & Co, had a softer year. Revenue rose 2.0% to £16.3 million, but operating profit was broadly flat at £4.8 million against £4.9 million last year.

The company says the Board’s review of strategic options, including an attempted sale of Bush & Co that ended in June 2025, caused some distraction. That feels believable. Sale processes have a habit of soaking up management time and slowing momentum.

There were still positives. Expert witness revenue grew 9% to £8.5 million, 1,454 reports were delivered, and new instructions rose 4%. Bush & Co. Care Solutions also grew revenue 21% to £0.9 million, all recurring revenue.

The weaker area was case management, where revenue fell 6% to £6.9 million. New instructions from insurers were down sharply versus 2023, and discharges from ongoing cases increased. That is not disastrous, but it does show this division is not firing on all cylinders yet.

NAHL outlook for 2026: decent start, but lower settlements could mean lower cash later

Trading in the first quarter of 2026 was in line with Board expectations, and revenue was up 3% year on year. That is a solid start rather than a blockbuster one.

In Personal Injury, enquiries were up 13% to 3,983, though average cost per enquiry was around 10% higher than in 2023. NAL placed 1,220 new enquiries in Q1, expected to generate £1.7 million of future revenue and cash.

There is a catch, though. NAL settled 851 claims in Q1 versus 950 a year earlier, generating £2.7 million of settlement cash compared with £2.8 million. Management expects fewer settlements than last year because it started 2026 with fewer open claims.

That links back to the shrinking case book. The company also explicitly says it expects lower levels of free cash flow for the rest of 2026 due to fewer case settlements in NAL. Investors should not ignore that warning just because Q1 debt reduction looked strong.

Bank facility extension and strategic options: reassuring, but still unresolved

One quietly positive development is the refinancing. In May 2026, NAHL extended its banking facility with Virgin Money through to 31 December 2027, while reducing the revolving credit facility from £11.0 million to £8.5 million.

That tells you two things. First, the bank is still supportive. Second, NAHL simply does not need as much borrowing as it used to, which is a nice problem to have.

The other ongoing issue is strategy. The Board says it continues to explore options to accelerate value for shareholders. What those options are, beyond what has already been discussed, is not disclosed.

That leaves a bit of uncertainty in the story. Strategic reviews can unlock value, but they can also drag on and frustrate investors if nothing concrete emerges.

Dividend decision and final verdict on NAHL shares after FY2025 results

There is still no dividend. The Board says it is not appropriate to reinstate one at present. I think that is the right call. With net debt still above zero and the NAL case book under pressure, keeping capital inside the business looks sensible.

Overall, this is a good set of results. NAHL has improved profitability, repaired margins, generated strong cash and cut debt sharply. Those are all real positives.

But it is not a perfect picture. The shrinking NAL claims book is the main issue, and it matters because it could cap growth and reduce future settlement cash if not addressed. Bush & Co also needs to turn a steady performance into something stronger.

My read is straightforward: NAHL is in better shape than it was a year ago, and materially less risky thanks to lower debt. The next question is whether management can convert that healthier position into sustainable growth, rather than just a very efficient run-off of existing claims.